Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥55.69 Million ≈ $8.15 Million USD) by net assets (CN¥1.33 Billion ≈ $194.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603811 stock market capitalisation for the company's overall valuation and market capitalisation.

Zhejiang Cheng Yi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 603811 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Guangzhou Jiacheng SHG:603535	0.033x
Bosun Tools Co Ltd SHE:002282	0.039x
Eastnine AB (publ) ST:EAST	0.013x
Lake Materials Co. Ltd. KQ:281740	0.006x
Haypp Grp Ab ST:HAYPP	0.035x
Eson Precision Ind Co Ltd TW:5243	0.063x
WHA UTILITIES AND PO BK:WHAUP-R	0.024x
ScinoPharm Taiwan Ltd TW:1789	0.019x

Annual Cash Flow Conversion Efficiency for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025. View today's stock price for Zhejiang Cheng Yi Pharmaceutical Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.40 Billion ≈ $204.54 Million	CN¥280.39 Million ≈ $41.03 Million	0.201x	+23.36%
2024-12-31	CN¥1.27 Billion ≈ $185.12 Million	CN¥205.72 Million ≈ $30.10 Million	0.163x	-0.10%
2023-12-31	CN¥1.20 Billion ≈ $175.10 Million	CN¥194.78 Million ≈ $28.50 Million	0.163x	+7.02%
2022-12-31	CN¥1.09 Billion ≈ $159.64 Million	CN¥165.94 Million ≈ $24.28 Million	0.152x	+5.89%
2021-12-31	CN¥998.88 Million ≈ $146.17 Million	CN¥143.49 Million ≈ $21.00 Million	0.144x	-28.41%
2020-12-31	CN¥886.09 Million ≈ $129.66 Million	CN¥177.81 Million ≈ $26.02 Million	0.201x	-14.76%
2019-12-31	CN¥768.96 Million ≈ $112.52 Million	CN¥181.01 Million ≈ $26.49 Million	0.235x	+18.06%
2018-12-31	CN¥673.54 Million ≈ $98.56 Million	CN¥134.30 Million ≈ $19.65 Million	0.199x	+79.10%
2017-12-31	CN¥599.57 Million ≈ $87.74 Million	CN¥66.75 Million ≈ $9.77 Million	0.111x	-67.19%
2016-12-31	CN¥280.17 Million ≈ $41.00 Million	CN¥95.08 Million ≈ $13.91 Million	0.339x	+7.65%
2015-12-31	CN¥259.92 Million ≈ $38.03 Million	CN¥81.94 Million ≈ $11.99 Million	0.315x	-7.44%
2014-12-31	CN¥246.95 Million ≈ $36.14 Million	CN¥84.11 Million ≈ $12.31 Million	0.341x	+42.35%
2013-12-31	CN¥201.40 Million ≈ $29.47 Million	CN¥48.19 Million ≈ $7.05 Million	0.239x	+12.28%
2012-12-31	CN¥178.13 Million ≈ $26.07 Million	CN¥37.96 Million ≈ $5.55 Million	0.213x	+117.73%
2011-12-31	CN¥102.60 Million ≈ $15.01 Million	CN¥10.04 Million ≈ $1.47 Million	0.098x	--

About Zhejiang Cheng Yi Pharmaceutical Co Ltd

SHG:603811 China Drug Manufacturers - Specialty & Generic

Market Cap

$470.04 Million

CN¥3.21 Billion CNY

Market Cap Rank

#12759 Global

#3790 in China

Share Price

CN¥7.01

Change (1 day)

-0.14%

52-Week Range

CN¥6.68 - CN¥13.35

All Time High

CN¥19.93